These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Management of osteitis deformans--diphosphonate, calcitonin or mitramycin?]. Tørring O Lakartidningen; 1981 Aug; 78(34):2831-2. PubMed ID: 6459502 [No Abstract] [Full Text] [Related]
24. [Letter: Results of treatment of Paget's disease of bone with swine thyrocalcitonin]. Bouvier M; Lejeune E; Daumont R; Deplante JP Nouv Presse Med; 1975 Dec; 4(43):3070-1. PubMed ID: 1223792 [No Abstract] [Full Text] [Related]
25. Effect of a long-term treatment with the aminosuberic analog of eel calcitonin on osteocalcin in Paget's disease. Caniggia A; Nuti R; Galli M; Turchetti V; Righi G Panminerva Med; 1987; 29(1):1-5. PubMed ID: 3496574 [No Abstract] [Full Text] [Related]
26. New drugs for treatment of Paget's disease. Med Lett Drugs Ther; 1972 Mar; 14(7):23-4. PubMed ID: 4346221 [No Abstract] [Full Text] [Related]
27. [Treatment of Paget's disease with the combined administration of calcitonin and disodium etidronate]. Ghiringhelli G; Fogel M; Varela de Rodríguez J; Casco C; Mautelén C; Nusimovich B Medicina (B Aires); 1982; 42(1):16-20. PubMed ID: 6813634 [No Abstract] [Full Text] [Related]
28. [Therapeutic sequences calcitonin-EHDP and EHDP-calcitonin in Paget's disease. Histological and biological study]. Eisinger J; Laponche AM; Ouaniche J Rev Rhum Mal Osteoartic; 1986 Mar; 53(3):183-5. PubMed ID: 3085204 [No Abstract] [Full Text] [Related]
29. [Calcitonin as a therapeutic drug]. Ziegler R Ther Umsch; 1985 Jun; 42(6):358-65. PubMed ID: 2410993 [No Abstract] [Full Text] [Related]
30. [Influence of porcine calcitonin in 3 healthy patients and in a female patient with Paget's disease]. Aznar Reig A; Zamora Madaria E; Herrera Justiniano E; Rubio Rubio JM; Gómez San Millán M; Merchante C Rev Iber Endocrinol; 1971; 18(107):419-42. PubMed ID: 5133441 [No Abstract] [Full Text] [Related]
33. [Paget's disease with obstructive communicating hydrocephalus and dementia. Favorable outcome under the treatment with calcitonin]. Detilleux M; Guillausseau PJ; Caquet R; Reynaud M; Metzger J; Askienazy S; Laroche C Ann Med Interne (Paris); 1977; 128(8-9):667-72. PubMed ID: 921128 [No Abstract] [Full Text] [Related]
34. [Short term treatment of Paget's disease with porcine calcitonin]. Renier JC; Boasson M; Jallet P; Bernat M Rev Rhum Mal Osteoartic; 1973 Oct; 40(10):557-63. PubMed ID: 4797550 [No Abstract] [Full Text] [Related]
35. Calcitonin therapy for bone disease and hypercalcemia. Avioli LV Arch Intern Med; 1982 Nov; 142(12):2076-9. PubMed ID: 7138154 [No Abstract] [Full Text] [Related]
36. [Treatment of Paget's disease of bone: diphosphonates or calcitonin?]. Davoine GA; Jung A; Courvoisier B Schweiz Med Wochenschr; 1981 Apr; 111(15):518-24. PubMed ID: 6785879 [TBL] [Abstract][Full Text] [Related]
37. [Treatment of the painful Paget's disease of the pelvis with salmon calcitonin in ambulant care. Studies in 2 cases during 26 and 19 months respectively]. Staehelin A Schweiz Med Wochenschr; 1975 Dec; 105(50):1704-5. PubMed ID: 1215961 [TBL] [Abstract][Full Text] [Related]
38. [Treatment with calcitonin]. Falch J Tidsskr Nor Laegeforen; 1979 Aug; 99(22):1007-8. PubMed ID: 483291 [No Abstract] [Full Text] [Related]
39. Synthetic human calcitonin in refractory Paget's disease of bone. Altman RD; Collins-Yudiskas B Arch Intern Med; 1987 Jul; 147(7):1305-8. PubMed ID: 3111398 [TBL] [Abstract][Full Text] [Related]
40. [Effects of the combined calcitonin and sodium etidronate therapy in Paget's disease of bone]. Nuti R; Turchetti V; Righi G; Vattimo A Minerva Med; 1982 Mar; 73(9):467-72. PubMed ID: 6801555 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]